- $43.83m
- $59.04m
- 13
- 12
- 77
- 26
2019 December 28th | 2021 January 2nd | R2022 December 31st | R2022 January 1st | 2023 December 30th | |
---|---|---|---|---|---|
Period Length: | 52 W | 53 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 35.1 | 33.9 | 0 | 40 | 0 |
Cost of Revenue | |||||
Gross Profit | 7.79 | 8.83 | 0 | 8.87 | 0 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 49.8 | 42.4 | 0.562 | 43.4 | 19.8 |
Operating Profit | -14.7 | -8.58 | -0.562 | -3.37 | -19.8 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -15.2 | -8.93 | 1.4 | -3.04 | -17.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12 | -8.5 | 8.02 | -3.31 | -17.1 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -12 | -8.5 | 11 | -16.9 | -7.81 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12 | -8.5 | 11 | -16.9 | -7.81 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -5.94 | -4.73 | 2.01 | -1.21 | -1.82 |